NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Jun 16 2023

· Issued by NATCO Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jun-16-2023-3

Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 16, 2023, titled "NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine (generic for Lonsurf��) for the US market".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases